Prostate-specific antigen testing rates remain low in UK general practice: A cross-sectional study in six English cities

Prostate-specific antigen testing rates remain low in UK general practice: A cross-sectional study in six English cities

Zobrazit další vydání (1)

OBJECTIVE To estimate rates of prostate-specific antigen (PSA) testing in UK general practices by age, deprivation index and geographical location. SUBJECTS AND METHODS Practice-based, retrospective data on PSA testing patterns in 2007 were collected from a random sample of 87 general practices usin...

Podrobná bibliografie
Hlavní autoři:	Williams, N, Hughes, L, Turner, E, Donovan, J, Hamdy, F, Neal, D, Martin, R, Metcalfe, C
Médium:	Journal article
Jazyk:	English
Vydáno:	2011

Podobné jednotky

Prostate-specific antigen testing rates remain low in UK general practice: a cross-sectional study in six English cities.
Autor: Williams, N, a další
Vydáno: (2011)

Prostate-specific antigen (PSA) testing of men in UK general practice: a 10-year longitudinal cohort study
Autor: Young, GJ, a další
Vydáno: (2017)

Seasonal variation in prostate-specific antigen levels: A large cross-sectional study of men in the UK
Autor: Down, L, a další
Vydáno: (2011)

Seasonal variation in prostate-specific antigen levels: a large cross-sectional study of men in the UK.
Autor: Down, L, a další
Vydáno: (2011)

Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK.
Autor: Brindle, L, a další
Vydáno: (2006)

Predictors of attendance for prostate-specific antigen screening tests and prostate biopsy.
Autor: Avery, K, a další
Vydáno: (2012)

Predictors of attendance for prostate-specific antigen screening tests and prostate biopsy
Autor: Avery, K, a další
Vydáno: (2012)

Screening for prostate cancer remains controversial.
Autor: Neal, D, a další
Vydáno: (2009)

Population-based prostate-specific antigen testing in the UK leads to a stage migration of prostate cancer.
Autor: Moore, A, a další
Vydáno: (2009)

Do the risk factors of age, family history of prostate cancer or a higher prostate specific antigen level raise anxiety at prostate biopsy?
Autor: Macefield, R, a další
Vydáno: (2009)

Longitudinal prostate-specific antigen reference ranges: Choosing the underlying model of age-related changes
Autor: Simpkin, A, a další
Vydáno: (2013)

Prostate-specific antigen testing and prostate biopsy: are self-reported lower urinary tract symptoms and health-related quality of life associated with the decision to undergo these investigations?
Autor: Avery, K, a další
Vydáno: (2008)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study
Autor: Rosario, D, a další
Vydáno: (2012)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study.
Autor: Rosario, D, a další
Vydáno: (2012)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: Prospective evaluation within ProtecT study
Autor: Rosario, D, a další
Vydáno: (2012)

Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen
Autor: Harrison, S, a další
Vydáno: (2020)

ASSOCIATION OF ANTHROPOMETRIC AND LIFESTYLE FACTORS WITH PROSTATE SPECIFIC ANTIGEN (PSA) TRAJECTORIES IN MEN WITH LOCALISED PROSTATE CANCER UNDERGOING ACTIVE MONITORING
Autor: Burton, A, a další
Vydáno: (2011)

Latest results from the UK trials evaluating prostate cancer screening and treatment: the CAP and ProtecT studies.
Autor: Lane, J, a další
Vydáno: (2010)

Associations of folate, vitamin B12, homocysteine, and folate-pathway polymorphisms with prostate-specific antigen velocity in men with localized prostate cancer.
Autor: Collin, S, a další
Vydáno: (2010)

ASSOCIATIONS OF SEXUAL DYSFUNCTION WITH LOCALIZED AND ADVANCED PROSTATE CANCER: A CASE-CONTROL STUDY NESTED WITHIN THE UK POPULATION-BASED PROTECT (PROSTATE TESTING FOR CANCER AND TREATMENT) STUDY
Autor: Collin, S, a další
Vydáno: (2009)

Investigating the prostate specific antigen, body mass index and age relationship: is an age-BMI-adjusted PSA model clinically useful?
Autor: Harrison, S, a další
Vydáno: (2016)

Prostate cancer detection in men aged 45-49 years in the UK protect (prostate testing for cancer and treatment) trial
Autor: Hamdy, F, a další
Vydáno: (2006)

Development of a new method for monitoring prostate-specific antigen changes in men with localised prostate cancer: a comparison of observational cohorts.
Autor: Tilling, K, a další
Vydáno: (2010)

The protecT (prostate testing for cancer and treatment) study: Evaluating screening and treatment of clinically localised prostate cancer in the UK
Autor: Hamdy, F, a další
Vydáno: (2006)

The relationship between prostate-specific antigen and prostate cancer risk: the Prostate Biopsy Collaborative Group.
Autor: Vickers, A, a další
Vydáno: (2010)

Associations of sexual dysfunction symptoms with PSA-detected localised and advanced prostate cancer: a case-control study nested within the UK population-based ProtecT (Prostate testing for cancer and Treatment) study.
Autor: Collin, S, a další
Vydáno: (2009)

Association of diabetes mellitus with prostate cancer: nested case-control study (Prostate testing for cancer and treatment study).
Autor: Turner, E, a další
Vydáno: (2011)

Serum insulin-like growth factor-I is positively associated with serum prostate-specific antigen in middle-aged men without evidence of prostate cancer.
Autor: Oliver, SE, a další
Vydáno: (2004)

The protect (prostate testing for cancer and treatment) study: Advanced cases found through a UK screening study
Autor: Neal, D, a další
Vydáno: (2006)

Prostate Specific Antigen Levels Among Men With Prostate Cancer in Ramadi City
Autor: Jalil Ibrahim Salih, a další
Vydáno: (2013-08-01)

Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologies
Autor: Nouira Yassin, a další
Vydáno: (2010-12-01)

First report of prostate-specific membrane antigen-targeted immunotherapy in prostate cancer: the future is bright
Autor: Lamb, A, a další
Vydáno: (2018)

Screening for prostate cancer. The case against.
Autor: Donovan, J, a další
Vydáno: (2005)

The performance characteristics of prostate-specific antigen and prostate-specific antigen density in Chinese men
Autor: Jeremy YC Teoh, a další
Vydáno: (2017-01-01)

10-year outcomes in localized prostate cancer.
Autor: Hamdy, F, a další
Vydáno: (2017)

Value of Prostate-Specific Antigen and Prostate-Specific Antigen Density in Detection of Prostate Cancer in an Iranian Population of Men
Autor: Mahyar Ghafoori, a další
Vydáno: (2009-08-01)

Prostatic specific antigen for prostate cancer detection
Autor: Lucas Nogueira, a další
Vydáno: (2009-10-01)

Benign prostatic hyperplasia and prostate-specific antigen
Autor: Pejčić Tomislav, a další
Vydáno: (2015-01-01)

Lifestyle factors and prostate-specific antigen (PSA) testing in UK Biobank: Implications for epidemiological research
Autor: Littlejohns, T, a další
Vydáno: (2016)

Biology of prostate-specific antigen
Autor: Lilja, H
Vydáno: (2003)